Cardiac Autonomic Function and Cardiovascular Response to Exercise in Patients with Chronic Obstructive Pulmonary Disease

References

• O’Donell DE, Lavenesiana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006; 100:61–67 and 1993; 148:1351–1357.
   Google Scholar
• Simpson K, Killian K, McCartney N, Randomized controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992; 47:70–75.
   PubMed Web of Science ®Google Scholar
• Decramer M, Gosselink R, Troosters T, Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10:417–423.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Lange P, Benet M, Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61:772–778.
   PubMed Web of Science ®Google Scholar
• Van Gestel AJR, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J Thorac Dis 2010; 2:215–222.
   Google Scholar
• Heindl S, Lehnert M, Criée CP. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164:597–601.
   PubMed Web of Science ®Google Scholar
• Volterrani M, Scalvini S, Mazzuero G. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106:1432–1437.
   PubMed Web of Science ®Google Scholar
• Stewart AG, Waterhouse JC, Howard P. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J 1991; 4:1207–1214.
   PubMed Web of Science ®Google Scholar
• Bilmann, GE, Schwartz, PJ, Stone, HL. Baro-receptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982; 66:874–880.
   PubMed Web of Science ®Google Scholar
• American Heart Association. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17:354–381.
   PubMed Web of Science ®Google Scholar
• Stein PK, Nelson P, Rottman JN, Howard D, Heart rate variability reflects severity of COPD in PiZ α1-antitrypsin deficiency. Chest 1998; 113:327–333.
   PubMed Web of Science ®Google Scholar
• Bauerle O, Chrusch CA, Younes M. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998; 157:57–68.
   PubMed Web of Science ®Google Scholar
• West JB, Wagner PD, Neder JA, The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation. J Appl Physiol 2008; 105:758–762.
   PubMed Web of Science ®Google Scholar
• Killian KJ, Leblanc P, Martin DH, Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146:935–940.
   PubMed Web of Science ®Google Scholar
• Muriari C, Ghezzo H, Milic-Emili J, Gauthier H. Exercise limitation in obstructive lung disease. Chest 1998; 114:965–968.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society and European Respiratory Society. Statements on skeletal muscle dysfunction in COPD. Am J Respir Crit Care Med 1999; 159 (suppl): 1029–1356 and Eur Respir J 2000; 15: 807–815.
   PubMedGoogle Scholar
• Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153:976–980.
   PubMed Web of Science ®Google Scholar
• Neder JA, Jones PW, Nery LE, Whipp BJ. Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:497–504.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 1993; 148:1351–1357.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Bertley JC, Chau LKL, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation. Am J Respir Crit Care Med 1997; 155:109–115.
   PubMed Web of Science ®Google Scholar
• Varray A, Pre´faut C. Exercise training in patients with respiratory disease: procedures and results. Eur Respir Rev 1995; 5:51–58.
   Google Scholar
• Pitta F, Troosters T, Spruit MA, Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(9):972–977.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society Statement. Guidelines for the six-minute walk test. Am J Respir Care Med 2002; 166:111–117.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Chron Respir Dis 2010; 7(3):131–133.
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V. Burgos F, et al. Series “ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• Miller MR, Crapo R, Hankinson J, General considerations for lung function testing. Eur Respir J 2005; 26:153–161.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society/American College of Chest Physicians. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 2003; 167:211–277.
   PubMed Web of Science ®Google Scholar
• Kroidl RF, Schwarz S, Lehnigk B. Kursbuch Spiroergometrie. Georg Thieme Verlag 2007; 3.
   Google Scholar
• Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity—a cross-sectional study. Am J Respir Crit Care Med 2008; 177:743–751.
   PubMed Web of Science ®Google Scholar
• Patel SA, Benzo RP, Slivka WA, Sciurba FC. Activity monitoring and energy expenditure in COPD patients: a validation study. COPD 2007; 4:107–112.
   PubMedGoogle Scholar
• Jolley CJ, Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev 2009; 18:66–79.
   PubMedGoogle Scholar
• Watz H, Waschki B, Meyer T, Kretschmar G, Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010; 138(1):32–38.
   PubMed Web of Science ®Google Scholar
• Barr RG, Bluemke DA, Ahmed FS, Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling. N Engl J Med 2010; 362:217–227.
   PubMed Web of Science ®Google Scholar
• Kuo TB, Lin T, Yang CC, Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999; 277:233–239.
   Google Scholar
• Sinnreich R, Kark JD, Friedlander Y, Five minute recordings of heart rate variability for population studies: repeatability and age–sex characteristics. Heart 1998; 80:156–162.
   PubMed Web of Science ®Google Scholar
• Andreas S, Anker SD, Scanlon PD, Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005; 128:3618–3624.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14–20.
   PubMed Web of Science ®Google Scholar
• van Gestel AJR, Kohler M, Steier J, Teschler S, Cardiac autonomic dysfunction and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2011; 12:1440–1843.
   Google Scholar